Guidelines of care for the management of atopic dermatitis: Section 3. Management and treatment with phototherapy and systemic agents
Sidbury, R.; Davis, D. M.; Cohen, D. E.; Cordoro, K. M.; Berger, T. G.; Bergman, J. N.; Chamlin, S. L.; Cooper, K. D.; Feldman, S. R.; Hanifin, J. M.; Krol, A.; Margolis, D. J.; Paller, A. S.; Schwarzenberger, K.; Silverman, R. A.; Simpson, E. L.; Tom, W. L.; Williams, H. C.; Elmets, C. A.; Block, J.; Harrod, C. G.; Begolka, W. S.; Eichenfield, L. F.
J Am Acad Dermatol. 2014 May 13; 71(2):327-49
Atopic dermatitis is a chronic, pruritic inflammatory dermatosis that affects up to 25% of children and 2% to 3% of adults. This guideline addresses important clinical questions that arise in atopic dermatitis management and care, providing recommendations based on the available evidence. In this third of 4 sections, treatment of atopic dermatitis with phototherapy and systemic immunomodulators, antimicrobials, and antihistamines is reviewed, including indications for use and the risk-benefit profile of each treatment option.